Showing results (81-90 of 96) with videos related to

Sort By:
Pageof 10
International Journal of Hematology|May 4, 2026
Allogeneic hematopoietic cell transplantation for acute myeloid leukemia in Japan: changes in practice patterns and outcomes during the past 20 yearsMasamitsu Yanada, Yoshimitsu Shimomura, Satoshi Yamasaki, et al.
International Journal of Hematology|December 14, 2022
Effect of the COVID-19 pandemic on allogeneic stem cell transplantation in JapanYoshimitsu Shimomura, Tetsuhisa Kitamura, Masashi Nishikubo, et al.
Transplantation and Cellular Therapy|April 10, 2021
Single Cord Blood Transplantation Versus Unmanipulated Haploidentical Transplantation for Adults with Acute Myeloid Leukemia in Complete RemissionTakaaki Konuma, Junya Kanda, Satoshi Yamasaki, et al.
European Journal of Haematology|March 25, 2023
Trajectories of the SARS-CoV-2 RNA load in patients with hematological malignancySatoshi Mitsuyuki, Masashi Nishikubo, Yoshimitsu Shimomura, et al.
Bone Marrow Transplantation|September 30, 2024
Impact of donor type on the outcomes of acute graft versus host disease to systemic corticosteroid therapyYoshimitsu Shimomura, Tetsuhisa Kitamura, Junichi Sugita, et al.
British Journal of Haematology|October 19, 2023
The prognosis and risk factors for patients with complex karyotype myelodysplastic syndrome undergoing allogeneic haematopoietic stem cell transplantationYoshimitsu Shimomura, Sho Komukai, Tetsuhisa Kitamura, et al.
Blood Advances|January 15, 2026
GVHD prophylaxis after cord blood transplantation in patients with high-risk AML: a nationwide Japanese cohort studySatoshi Yamasaki, Masamitsu Yanada, Shohei Mizuno, et al.
Transplantation and Cellular Therapy|February 22, 2026
Can cord blood unit selection improve outcomes after single-unit unrelated cord blood transplantation for non-remission acute myeloid leukemia?Takaaki Konuma, Yoshimitsu Shimomura, Satoshi Yamasaki, et al.
British Journal of Haematology|June 16, 2025
Prognostic factors for allogeneic haematopoietic cell transplantation outcomes in primary refractory acute myeloid leukaemia (2013-2022): A retrospective study by the adult acute myeloid leukaemia working group of the Japanese Society for Transplantation and Cellular TherapyTakaaki Konuma, Yoshimitsu Shimomura, Shohei Mizuno, et al.
Cytotherapy|December 3, 2024
Allogeneic hematopoietic stem cell transplantation using reduced intensity conditioning regimen for patients with acute myeloid leukemia not in complete remissionYoshimitsu Shimomura, Tetsuhisa Kitamura, Masamitsu Yanada, et al.
Pageof 10